NCT06584617 - The Purpose of This Study is to Assess Clinical Efficacy and Safety of Berovenal® Intended to Promote Treatment and to Expedite Chronic Diabetic Foot Ulcer Healing | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions

Diabetic Foot Ulcer

Interventions

DEVICE

Berovenal®

Easy to spread, water-washable, light brown, turbid hydrogel in tube containing 30 g of hydrogel and closed with a plastic screw cap.

DEVICE

NU-GEL Hydrogel with Alginate

Transparent, easy to spread and water-washable hydrogel in ampoule (concertina pack) containing 25 g or 15 g of hydrogel and closed with a plastic cap.

Trial Locations (9)

69120

RECRUITING

Universitätsklinikum Heidelberg, Heidelberg

85092

RECRUITING

Klinik Kösching, Kösching

41-500

RECRUITING

Diab Serwis Popenda Spółka Jawna, Chorzów

80-214

RECRUITING

Uniwersyteckie Centrum Kliniczne, Gdansk

31-261

RECRUITING

Medyczne Centrum Diabetologiczno Endokrynologiczno Metaboliczne DIAB-ENDO-MET, Krakow

94-238

RECRUITING

MIKOMED Sp. z o.o., Lodz

10-561

RECRUITING

Wojewódzka Poradnia Diabetologiczna, Gabinet Stopy Cukrzycowej, Olsztyn

60-111

RECRUITING

Centrum Medyczne Omedica Jarosław Opiela I Beata Opiela Spółka Jawna, Poznan

50-414

RECRUITING

Ginemedica Sp. z o.o. Sp. k., Wroclaw